APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Herpersvirus 5 (HHV-5) Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Human Herpersvirus 5 (HHV-5) Drug Market Outlook and Growth Opportunities 2026

22 December 2025191 pages

Choose your research edition.

Industry ResearchHuman Herpersvirus 5 (HHV-5) Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Herpersvirus 5 (HHV-5) Drug Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Human Herpersvirus 5 (HHV-5) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Herpersvirus 5 (HHV-5) Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Herpersvirus 5 (HHV-5) Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Human Herpersvirus 5 (HHV-5) Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Human Herpersvirus 5 (HHV-5) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Herpersvirus 5 (HHV-5) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Herpersvirus 5 (HHV-5) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Human Herpersvirus 5 (HHV-5) Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Human Herpersvirus 5 (HHV-5) Drug market include Chongqing Fu'an Pharmaceutical, Yangtze River Pharmaceutical, Wuhan Hualong, Sichuan Cologne Pharmaceutical, Shandong Luo Xin Pharmaceutical, Roche, Qianjiang Pharmaceuticals, GlaxoSmithKline and Upright and clear, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Herpersvirus 5 (HHV-5) Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Herpersvirus 5 (HHV-5) Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Herpersvirus 5 (HHV-5) Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Herpersvirus 5 (HHV-5) Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Herpersvirus 5 (HHV-5) Drug Segment by Company

Chongqing Fu'an Pharmaceutical

Yangtze River Pharmaceutical

Wuhan Hualong

Sichuan Cologne Pharmaceutical

Shandong Luo Xin Pharmaceutical

Roche

Qianjiang Pharmaceuticals

GlaxoSmithKline

Upright and clear

On the drug new Asia

Livzon Pharmaceuticals

Hubei Branch benefits medicine

Haikou Kellett

Chongqing Winbond (acquisition of Sichuan Mingxin)

Human Herpersvirus 5 (HHV-5) Drug Segment by Type

Valerian Gilivir Drugs

Foscarnet Sodium Drugs

Ganciclovir

Valacyclovir Drugs

Acyclovir Drugs

Human Herpersvirus 5 (HHV-5) Drug Segment by Application

Organ Transplant Crowd

Immunodeficiency Crowd

CMV Herpes Crowd

Human Herpersvirus 5 (HHV-5) Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Human Herpersvirus 5 (HHV-5) Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Human Herpersvirus 5 (HHV-5) Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Human Herpersvirus 5 (HHV-5) Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Human Herpersvirus 5 (HHV-5) Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Herpersvirus 5 (HHV-5) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Herpersvirus 5 (HHV-5) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Herpersvirus 5 (HHV-5) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Herpersvirus 5 (HHV-5) Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Herpersvirus 5 (HHV-5) Drug industry.

Chapter 3: Detailed analysis of Human Herpersvirus 5 (HHV-5) Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Human Herpersvirus 5 (HHV-5) Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Human Herpersvirus 5 (HHV-5) Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Human Herpersvirus 5 (HHV-5) Drug Industry Trends Table 2. Human Herpersvirus 5 (HHV-5) Drug Industry Drivers Table 3. Human Herpersvirus 5 (HHV-5) Drug Industry Opportunities and Challenges Table 4. Human Herpersvirus 5 (HHV-5) Drug Industry Restraints Table 5. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Company (2021-2026) Table 7. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Company (k units) & (2021-2026) Table 8. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume Share by Company (2021-2026) Table 9. Global Human Herpersvirus 5 (HHV-5) Drug Average Price (US$/unit) of Company (2021-2026) Table 10. Global Human Herpersvirus 5 (HHV-5) Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Human Herpersvirus 5 (HHV-5) Drug Key Company Manufacturing Base & Headquarters Table 12. Global Human Herpersvirus 5 (HHV-5) Drug Company, Product Type & Application Table 13. Global Human Herpersvirus 5 (HHV-5) Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Herpersvirus 5 (HHV-5) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Valerian Gilivir Drugs Table 18. Significant Companies of Foscarnet Sodium Drugs Table 19. Significant Companies of Ganciclovir Table 20. Significant Companies of Valacyclovir Drugs Table 21. Significant Companies of Acyclovir Drugs Table 22. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Type (2021-2026) & (k units) Table 24. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Type (2027-2032) & (k units) Table 25. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume Share by Type (2021-2026) Table 26. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume Share by Type (2027-2032) Table 27. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type (2021-2026) Table 31. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Organ Transplant Crowd Table 33. Significant Companies of Immunodeficiency Crowd Table 34. Significant Companies of CMV Herpes Crowd Table 35. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Application (2021-2026) & (k units) Table 37. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Application (2027-2032) & (k units) Table 38. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume Share by Application (2021-2026) Table 39. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume Share by Application (2027-2032) Table 40. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application (2021-2026) Table 44. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application (2027-2032) Table 45. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2021-2026) & (k units) Table 47. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region (2021-2026) Table 48. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2027-2032) & (k units) Table 49. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region (2027-2032) Table 50. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Region (2021-2026) Table 53. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Region (2027-2032) Table 55. Global Human Herpersvirus 5 (HHV-5) Drug Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Human Herpersvirus 5 (HHV-5) Drug Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026) & (k units) Table 60. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country (2021-2026) Table 61. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2027-2032) & (k units) Table 62. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country (2027-2032) Table 63. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Market Share by Country (2021-2026) Table 65. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Market Share by Country (2027-2032) Table 67. Chongqing Fu'an Pharmaceutical Company Information Table 68. Chongqing Fu'an Pharmaceutical Business Overview Table 69. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 71. Chongqing Fu'an Pharmaceutical Recent Development Table 72. Yangtze River Pharmaceutical Company Information Table 73. Yangtze River Pharmaceutical Business Overview Table 74. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 76. Yangtze River Pharmaceutical Recent Development Table 77. Wuhan Hualong Company Information Table 78. Wuhan Hualong Business Overview Table 79. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 81. Wuhan Hualong Recent Development Table 82. Sichuan Cologne Pharmaceutical Company Information Table 83. Sichuan Cologne Pharmaceutical Business Overview Table 84. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 86. Sichuan Cologne Pharmaceutical Recent Development Table 87. Shandong Luo Xin Pharmaceutical Company Information Table 88. Shandong Luo Xin Pharmaceutical Business Overview Table 89. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 91. Shandong Luo Xin Pharmaceutical Recent Development Table 92. Roche Company Information Table 93. Roche Business Overview Table 94. Roche Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Roche Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 96. Roche Recent Development Table 97. Qianjiang Pharmaceuticals Company Information Table 98. Qianjiang Pharmaceuticals Business Overview Table 99. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 101. Qianjiang Pharmaceuticals Recent Development Table 102. GlaxoSmithKline Company Information Table 103. GlaxoSmithKline Business Overview Table 104. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 106. GlaxoSmithKline Recent Development Table 107. Upright and clear Company Information Table 108. Upright and clear Business Overview Table 109. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 111. Upright and clear Recent Development Table 112. On the drug new Asia Company Information Table 113. On the drug new Asia Business Overview Table 114. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 116. On the drug new Asia Recent Development Table 117. Livzon Pharmaceuticals Company Information Table 118. Livzon Pharmaceuticals Business Overview Table 119. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 121. Livzon Pharmaceuticals Recent Development Table 122. Hubei Branch benefits medicine Company Information Table 123. Hubei Branch benefits medicine Business Overview Table 124. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 126. Hubei Branch benefits medicine Recent Development Table 127. Haikou Kellett Company Information Table 128. Haikou Kellett Business Overview Table 129. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 131. Haikou Kellett Recent Development Table 132. Chongqing Winbond (acquisition of Sichuan Mingxin) Company Information Table 133. Chongqing Winbond (acquisition of Sichuan Mingxin) Business Overview Table 134. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 136. Chongqing Winbond (acquisition of Sichuan Mingxin) Recent Development Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Human Herpersvirus 5 (HHV-5) Drug Distributors List Table 140. Human Herpersvirus 5 (HHV-5) Drug Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Human Herpersvirus 5 (HHV-5) Drug Product Image Figure 2. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Human Herpersvirus 5 (HHV-5) Drug Sales (2021-2032) & (k units) Figure 5. Global Human Herpersvirus 5 (HHV-5) Drug Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Human Herpersvirus 5 (HHV-5) Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Valerian Gilivir Drugs Image Figure 10. Foscarnet Sodium Drugs Image Figure 11. Ganciclovir Image Figure 12. Valacyclovir Drugs Image Figure 13. Acyclovir Drugs Image Figure 14. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume Share by Type (2021-2032) Figure 17. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type (2021-2032) Figure 20. Organ Transplant Crowd Image Figure 21. Immunodeficiency Crowd Image Figure 22. CMV Herpes Crowd Image Figure 23. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume Share by Application (2021-2032) Figure 26. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application (2021-2032) Figure 29. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Human Herpersvirus 5 (HHV-5) Drug Sales Value (2021-2032) & (US$ Million) Figure 34. North America Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Human Herpersvirus 5 (HHV-5) Drug Sales Value (2021-2032) & (US$ Million) Figure 40. South America Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Human Herpersvirus 5 (HHV-5) Drug Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Human Herpersvirus 5 (HHV-5) Drug Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Valerian Gilivir Drugs
  • Foscarnet Sodium Drugs
  • Ganciclovir
  • Valacyclovir Drugs
  • Acyclovir Drugs
Applications
  • Organ Transplant Crowd
  • Immunodeficiency Crowd
  • CMV Herpes Crowd
Companies covered
  • Chongqing Fu'an Pharmaceutical
  • Yangtze River Pharmaceutical
  • Wuhan Hualong
  • Sichuan Cologne Pharmaceutical
  • Shandong Luo Xin Pharmaceutical
  • Roche
  • Qianjiang Pharmaceuticals
  • GlaxoSmithKline
  • Upright and clear
  • On the drug new Asia
  • Livzon Pharmaceuticals
  • Hubei Branch benefits medicine
  • Haikou Kellett
  • Chongqing Winbond (acquisition of Sichuan Mingxin)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value (2021-2032)
  4. 1.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Human Herpersvirus 5 (HHV-5) Drug Market Dynamics
  1. 2.1 Human Herpersvirus 5 (HHV-5) Drug Industry Trends
  2. 2.2 Human Herpersvirus 5 (HHV-5) Drug Industry Drivers
  3. 2.3 Human Herpersvirus 5 (HHV-5) Drug Industry Opportunities and Challenges
  4. 2.4 Human Herpersvirus 5 (HHV-5) Drug Industry Restraints
3 Human Herpersvirus 5 (HHV-5) Drug Market by Company
  1. 3.1 Global Human Herpersvirus 5 (HHV-5) Drug Company Revenue Ranking in 2025
  2. 3.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2021-2026)
  3. 3.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Human Herpersvirus 5 (HHV-5) Drug Average Price by Company (2021-2026)
  5. 3.5 Global Human Herpersvirus 5 (HHV-5) Drug Company Ranking (2024-2026)
  6. 3.6 Global Human Herpersvirus 5 (HHV-5) Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Human Herpersvirus 5 (HHV-5) Drug Company Product Type and Application
  8. 3.8 Global Human Herpersvirus 5 (HHV-5) Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Human Herpersvirus 5 (HHV-5) Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Human Herpersvirus 5 (HHV-5) Drug Market by Type
  1. 4.1 Human Herpersvirus 5 (HHV-5) Drug Type Introduction
  2. 4.1.1 Valerian Gilivir Drugs
  3. 4.1.2 Foscarnet Sodium Drugs
  4. 4.1.3 Ganciclovir
  5. 4.1.4 Valacyclovir Drugs
  6. 4.1.5 Acyclovir Drugs
  7. 4.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Type
  8. 4.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Type
  12. 4.3.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Type (2021-2032)
  14. 4.3.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type (2021-2032)
5 Human Herpersvirus 5 (HHV-5) Drug Market by Application
  1. 5.1 Human Herpersvirus 5 (HHV-5) Drug Application Introduction
  2. 5.1.1 Organ Transplant Crowd
  3. 5.1.2 Immunodeficiency Crowd
  4. 5.1.3 CMV Herpes Crowd
  5. 5.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Application
  6. 5.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Application
  10. 5.3.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application (2021-2032)
6 Human Herpersvirus 5 (HHV-5) Drug Regional Sales and Value Analysis
  1. 6.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2027-2032)
  5. 6.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Human Herpersvirus 5 (HHV-5) Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Human Herpersvirus 5 (HHV-5) Drug Sales Value (2021-2032)
  12. 6.6.2 North America Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Human Herpersvirus 5 (HHV-5) Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Human Herpersvirus 5 (HHV-5) Drug Sales Value (2021-2032)
  21. 6.9.2 South America Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Country, 2025 VS 2032
7 Human Herpersvirus 5 (HHV-5) Drug Country-level Sales and Value Analysis
  1. 7.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2027-2032)
  6. 7.4 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Human Herpersvirus 5 (HHV-5) Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Human Herpersvirus 5 (HHV-5) Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Fu'an Pharmaceutical
  2. 8.1.1 Chongqing Fu'an Pharmaceutical Company Information
  3. 8.1.2 Chongqing Fu'an Pharmaceutical Business Overview
  4. 8.1.3 Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  6. 8.1.5 Chongqing Fu'an Pharmaceutical Recent Developments
  7. 8.2 Yangtze River Pharmaceutical
  8. 8.2.1 Yangtze River Pharmaceutical Company Information
  9. 8.2.2 Yangtze River Pharmaceutical Business Overview
  10. 8.2.3 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  12. 8.2.5 Yangtze River Pharmaceutical Recent Developments
  13. 8.3 Wuhan Hualong
  14. 8.3.1 Wuhan Hualong Company Information
  15. 8.3.2 Wuhan Hualong Business Overview
  16. 8.3.3 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  18. 8.3.5 Wuhan Hualong Recent Developments
  19. 8.4 Sichuan Cologne Pharmaceutical
  20. 8.4.1 Sichuan Cologne Pharmaceutical Company Information
  21. 8.4.2 Sichuan Cologne Pharmaceutical Business Overview
  22. 8.4.3 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  24. 8.4.5 Sichuan Cologne Pharmaceutical Recent Developments
  25. 8.5 Shandong Luo Xin Pharmaceutical
  26. 8.5.1 Shandong Luo Xin Pharmaceutical Company Information
  27. 8.5.2 Shandong Luo Xin Pharmaceutical Business Overview
  28. 8.5.3 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  30. 8.5.5 Shandong Luo Xin Pharmaceutical Recent Developments
  31. 8.6 Roche
  32. 8.6.1 Roche Company Information
  33. 8.6.2 Roche Business Overview
  34. 8.6.3 Roche Human Herpersvirus 5 (HHV-5) Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Roche Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  36. 8.6.5 Roche Recent Developments
  37. 8.7 Qianjiang Pharmaceuticals
  38. 8.7.1 Qianjiang Pharmaceuticals Company Information
  39. 8.7.2 Qianjiang Pharmaceuticals Business Overview
  40. 8.7.3 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  42. 8.7.5 Qianjiang Pharmaceuticals Recent Developments
  43. 8.8 GlaxoSmithKline
  44. 8.8.1 GlaxoSmithKline Company Information
  45. 8.8.2 GlaxoSmithKline Business Overview
  46. 8.8.3 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  48. 8.8.5 GlaxoSmithKline Recent Developments
  49. 8.9 Upright and clear
  50. 8.9.1 Upright and clear Company Information
  51. 8.9.2 Upright and clear Business Overview
  52. 8.9.3 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  54. 8.9.5 Upright and clear Recent Developments
  55. 8.10 On the drug new Asia
  56. 8.10.1 On the drug new Asia Company Information
  57. 8.10.2 On the drug new Asia Business Overview
  58. 8.10.3 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  60. 8.10.5 On the drug new Asia Recent Developments
  61. 8.11 Livzon Pharmaceuticals
  62. 8.11.1 Livzon Pharmaceuticals Company Information
  63. 8.11.2 Livzon Pharmaceuticals Business Overview
  64. 8.11.3 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  66. 8.11.5 Livzon Pharmaceuticals Recent Developments
  67. 8.12 Hubei Branch benefits medicine
  68. 8.12.1 Hubei Branch benefits medicine Company Information
  69. 8.12.2 Hubei Branch benefits medicine Business Overview
  70. 8.12.3 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  72. 8.12.5 Hubei Branch benefits medicine Recent Developments
  73. 8.13 Haikou Kellett
  74. 8.13.1 Haikou Kellett Company Information
  75. 8.13.2 Haikou Kellett Business Overview
  76. 8.13.3 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  78. 8.13.5 Haikou Kellett Recent Developments
  79. 8.14 Chongqing Winbond (acquisition of Sichuan Mingxin)
  80. 8.14.1 Chongqing Winbond (acquisition of Sichuan Mingxin) Company Information
  81. 8.14.2 Chongqing Winbond (acquisition of Sichuan Mingxin) Business Overview
  82. 8.14.3 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  84. 8.14.5 Chongqing Winbond (acquisition of Sichuan Mingxin) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Herpersvirus 5 (HHV-5) Drug Value Chain Analysis
  2. 9.1.1 Human Herpersvirus 5 (HHV-5) Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Herpersvirus 5 (HHV-5) Drug Sales Mode & Process
  6. 9.2 Human Herpersvirus 5 (HHV-5) Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Herpersvirus 5 (HHV-5) Drug Distributors
  9. 9.2.3 Human Herpersvirus 5 (HHV-5) Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst